{"disease":{"id":"acute-myeloid-leukemia-aml-relapse","name":"acute myeloid leukemia aml relapse"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02134782","title":"Yoga Fatigue Study","phase":"NA","overall_status":"TERMINATED","enrollment_count":125,"lead_sponsor_name":"The Hospital for Sick Children","has_results":false},{"nct_id":"NCT06648512","title":"Association of Ex Vivo Drug Response ( EVDR) and Clinical Outcome in Acute Myeloid Leukaemia (EXCYTE-2)","phase":"","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"Exscientia AI Limited","has_results":false},{"nct_id":"NCT06869265","title":"Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid Leukemia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":56,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT06754540","title":"Azacitidine Combined with Donor Lymphocyte Infusion for Acute Myeloid Leukemia Post-transplant Relapse Prevention.","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":51,"lead_sponsor_name":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT07087847","title":"Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute Leukemia","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":18,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT03207191","title":"Trial to Find and Investigate a Safe Dose of F16IL2 and BI 836858 in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Philogen S.p.A.","has_results":false},{"nct_id":"NCT06641648","title":"A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined with Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation.","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":12,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT04512105","title":"Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"University of California, Irvine","has_results":false},{"nct_id":"NCT05622591","title":"ELU001 in Pediatric Subjects Who Have Relapsed and/or Refractory CBFA2T3-GLIS2-positive AML","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Elucida Oncology","has_results":false},{"nct_id":"NCT03245424","title":"Ivosidenib Expanded Access Program in Relapsed/Refractory AML With an IDH1 Mutation","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Agios Pharmaceuticals, Inc.","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}